Justin Terry

Juristat’s normalized allowance rate factors in both average examiner allowance rate and the USPTO average allowance rate to provide a more specific metric to guide your patent prosecution strategy.

What Is a Normalized Allowance Rate?

Juristat’s normalized allowance rate factors in both average examiner allowance rate and the USPTO average allowance rate to provide a more specific metric to evaluate your patent prosecution strategy.

Read More

Mayo/Myriad at 10: On the Decline and in the Crosshairs

The Mayo/Myriad standard arguably introduced a great deal of uncertainty into the feasibility of obtaining patent protection for life sciences innovations and has been accused of curtailing the competitiveness of U.S.-based life sciences companies in the global marketplace.

Read More

Are you ready to transform your patent practice?

Patent prosecution is complex – we know. If you’re ready for simpler workflows and more predictable outcomes, give us a call.